Growth Engines
← Earnings Calls
01
02
03
04 05 06
Tone
AI
Capex
A1 A2 A3
ECL
FY2026 Q2
Improving
Ecolab Inc. earnings call
Buzzberg read
Global high-tech now approaching $1.5B annualized sales, up from $150M in 2021.
Ecolab reported strong Q2 2026 results with 5% organic sales growth, double-digit EPS growth, and raised full-year guidance. Management emphasized accelerating momentum in growth engines, particularly global high-tech (AI/data center) and life sciences, while managing commodity inflation through pricing. Organic sales growth accelerated to 5%, with 4% pricing and 1% volume despite Middle East headwinds.
Buzzberg read Global high-tech now approaching $1.5B annualized sales, up from $150M in 2021. Ecolab reported strong Q2 2026 results with 5% organic sales growth, double-digit EPS growth, and raised full-year guidance. Management emphasized accelerating momentum in growth engines, particularly global high-tech (AI/data center) and life sciences, while managing commodity inflation through pricing. Organic sales growth accelerated to 5%, with 4% pricing and 1% volume despite Middle East headwinds. Read full analysisCollapse analysis
Ecolab reported strong Q2 2026 results with 5% organic sales growth, double-digit EPS growth, and raised full-year guidance. Management emphasized accelerating momentum in growth engines, particularly global high-tech (AI/data center) and life sciences, while managing commodity inflation through pricing. Organic sales growth accelerated to 5%, with 4% pricing and 1% volume despite Middle East headwinds.
- Global high-tech sales up 29%, driven by AI infrastructure buildout; Cool IT acquisition closes and is expected to add ~2 points of growth.
- Life Sciences grew 15% with strong bioprocessing share gains; margins remain high but investment in capacity brings reported margins down.
- Ecolab Digital up 27%, with connected device deployments nearing 1 million.
Revenue$4.4154B+9% QoQ
EPS$2.09+23% QoQ
Gross margin44.07%Reported
Operating margin17.16%Reported
6 grounded callouts
What matters now
The highest-signal changes from the call.
Guidance
Raises global high-tech growth and margin targets to 25%+ and 25% by 2030.
Growth Engines
Life sciences accelerates to 15% growth with mid-20s OI margin.
Show 3 more callouts
Portfolio
Core business growth improved to mid-single digits in 2026.
Portfolio
Underperforming businesses stabilized, margins held in mid-teens.
Guidance
Second half organic sales growth guided to 6-7%.
Reported period
Actuals
| Metric | Reported | Change |
|---|---|---|
| Revenue | $4.4154B | +9% QoQ |
| EPS | $2.09 | +23% QoQ |
| Gross margin | 44.07% | Reported |
| Operating margin | 17.16% | Reported |
| Free cash flow | $0B | Reported |
| Capex | $0B | Reported |
Forward-looking
Forward guidance
| Metric | Period | Range | Midpoint | Status |
|---|---|---|---|---|
| EPS | FY2026 | $8.05–$8.25 | $8.15 | Raised |
AI, capex & demand read
Management read
Confident
Management expressed strong confidence in the portfolio's acceleration, raising long-term targets for global high-tech and reaffirming margin commitments.
Management AI read
AI infrastructure is driving very strong demand for the global high-tech business, which is now approaching $1.5B in sales and expected to grow more than 25% annually to $4B by 2030. The company is launching an integrated end-to-end cooling platform for data centers and hosting an investor day at Super Compute in November.
Investment and capacity
Management continues to invest ahead of growth in high-growth businesses like life sciences and global high-tech. Capital expenditures as a company are expected to remain around 7% of sales for the next couple of years as they scale these businesses.
all 2 named companies below
Companiesreturns since call
Supply chain
Supply chain
Christophe Beck
Global high-tech is now approaching $1.5B in annualized sales, driven by AI infrastructure buildout, and growing at 25%+ annually. — Demand for cooling and water solutions in data centers is surging, with implications for all AI infrastructure supply chains.
Evidence
“global high-tech is now approaching $1.5 billion in sales, annualized sales up from approximately 150 million in 2021”
External signals
Supply-chain alpha · 3returns since call
Global high-tech is now approaching $1.5B in annualized sales, driven by AI infrastructure buildout, and growing at 25%+ annually.
Life Sciences margins are being held below run-rate to invest in capacity expansion, with reported margin expected at high-teens in Q3 despite strong growth.
Evidence
“reported margin in the third quarter is expected to be in the high teens as we continue to invest in this high-growth, high-margin business.”
Cool IT's 50kW cold plate has customers 'wanting to be ahead of the queue', indicating supply-demand imbalance.
Evidence
“I see and hear customers not only wanting to be in the queue, but to be ahead of the queue because there's limited capacity”
Methodology & coverage
Management-only analysis. All 2 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.